Imprivata OneSign is now recognized as Google Chrome Enterprise Recommended

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Imprivata’s single sign-on solution is now Google Chrome Enterprise Recommended (CER), a program aimed at helping organizations find the apps that meet the highest quality assurance standards of Google’s engineering team

WALTHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) — Imprivata, the digital identity company for life-and mission-critical industries, today announced that Google has selected its single sign-on solution, Imprivata OneSign, for the Chrome Enterprise Recommended (CER) program. This program helps organizations maximize their Chrome Enterprise investments by providing a curated list of solutions that are evaluated and tested to ensure an optimal experience from integration to optimization. Imprivata’s single sign-on solution is used by over eight million healthcare providers to instantly access virtual desktops and on-premises and cloud apps, reducing login time by an average of 45 minutes per shift.

“Technology enabled workflows are essential to improving clinician lives and patient outcomes, so we’re excited and honored that our single sign-on solution has been recognized as Chrome Enterprise Recommended,” said Wes Wright, Chief Technology Officer of Imprivata. “Agility in healthcare isn’t a luxury, it’s a lifeline. To provide the best patient care possible, clinical staff need efficient and secure access to technology. This continued partnership with Google is a key step in enabling the healthcare of the future.”

For all endpoints running ChromeOS, Imprivata OneSign eliminates the need to repeatedly type usernames and passwords, with secure No Click Access™ via badge tap or biometrics while supporting regulatory compliance. Additional benefits include:

  • Instant clinical access to Chrome workstations and virtual desktop environments, including Citrix and VMware
  • Automatic sign on to Google Workspace (formerly G Suite) for seamless access to office productivity and collaboration tools
  • Secure patient access to entertainment and education on Chrome devices while receiving in-hospital care
  • NHS Spine access on Chrome devices without needing a physical smartcard or reader  

Together, Imprivata’s single sign-on solution and ChromeOS offer a seamless and secure mobile solution purpose-built for clinical workflows to mitigate the risk of cyberattacks and reduce the likelihood of practitioners charting under the wrong ID.

To learn more about Imprivata OneSign and Chrome Enterprise visit Imprivata.com/Google-CER.

About Imprivata

Imprivata is the digital identity company for life- and mission-critical industries, redefining how organizations solve complex workflow, security, and compliance challenges with solutions that protect critical data and applications without workflow disruption. Its platform of interoperable identity, authentication, and access management solutions enable organizations in over 45 countries to fully manage and secure all enterprise and third-party digital identities by establishing trust between people, technology, and information. For more information, visit www.imprivata.com.

Media Contact

press@imprivata.com

Staff

Recent Posts

AIM Congress 2025 Kicks Off in Abu Dhabi on Monday with 20,000 Participants

 Al Zeyoudi: "Hosting such major international events reflects the UAE's pivotal role as a global…

35 minutes ago

Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada

Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

13 hours ago

Makin Wellness Ranks No. 71 on Inc.’s 2025 List of the Fastest-Growing Private Companies in the Northeast

A leading provider of secure online therapy and counseling, offering a safe and supportive environment…

13 hours ago

Global Cancer Research Community Gathers to Share Breakthroughs at The Mark Foundation’s 2025 Scientific Symposium

NEW YORK, April 3, 2025 /PRNewswire/ -- The Mark Foundation for Cancer Research convened more than…

13 hours ago

FLO Living Partners with Leading Femtech Innovators to Conduct Study on the Cycle Syncing® Method

First-of-its-Kind Research Aims to Fill the Gap in Women's Hormonal Health NEW YORK, April 3,…

13 hours ago

SS&C to Release First Quarter 2025 Earnings

WINDSOR, Conn., April 3, 2025 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider…

13 hours ago